The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland

被引：0
|
作者：
Thomas Ward
Tray Brown
Ruth D. Lewis
Melodi Kosaner Kliess
Antonio Ramirez de Arellano
Carol M. Quinn
机构：
[1] Health Economics and Outcomes Research Ltd.,Health Economics Group, College of Medicine and Health
[2] University of Exeter,Vifor Pharma Group
[3] HEOR,undefined
[4] Vifor Pharma Group,undefined
[5] Medical Department,undefined
来源：
PharmacoEconomics - Open | 2022年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：757 / 771
页数：14
相关论文
共 50 条
  • [31] Heart Failure in Patients with Chronic Kidney Disease
    Xanthopoulos, Andrew
    Papamichail, Adamantia
    Briasoulis, Alexandros
    Loritis, Konstantinos
    Bourazana, Angeliki
    Magouliotis, Dimitrios E.
    Sarafidis, Pantelis
    Stefanidis, Ioannis
    Skoularigis, John
    Triposkiadis, Filippos
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (18)
  • [32] The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure
    Heerspink, J. L.
    Wheeler, D. C.
    Vart, P.
    Jongs, N.
    Hou, F. F.
    Langkilde, A. M.
    Correa-Rotter, R.
    Rossing, P.
    Sjostrom, C. D.
    Toto, R. D.
    Chertow, G. M.
    Stefansson, B. V.
    McMurray, J. J. V.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2913 - 2913
  • [33] COST-EFFECTIVENESS OF EMPAGLIFLOZIN IN THE TREATMENT OF PATIENTS WITH CHRONIC KIDNEY DISEASE IN FRANCE
    Supiot, R.
    Tardu, J.
    Virely, N.
    Sivignon, M.
    Chollet, J.
    Uster, A.
    Levy, P.
    Massy, Z.
    VALUE IN HEALTH, 2024, 27 (12) : S365 - S365
  • [34] Cost-Effectiveness of Ivabradine in the Treatment of Chronic Heart Failure
    Adena, Michael A.
    Hamann, Gary
    Sindone, Andrew P.
    HEART LUNG AND CIRCULATION, 2019, 28 (03): : 414 - 422
  • [35] THE COST-EFFECTIVENESS OF BETABLLOCKERS IN THE TREATMENT OF CHRONIC HEART FAILURE
    Lezha, Mimoza
    Miraci, Mirela
    Deliana, Artan
    Zera, Eliverta
    Temali, Indrit
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 140 : S59 - S60
  • [36] COST-EFFECTIVENESS ANALYSIS OF IVABRADINE IN THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE IN IRAN
    Taheri, S.
    Aivazi, A.
    Rasekh, H. R.
    VALUE IN HEALTH, 2017, 20 (09) : A617 - A617
  • [37] Drug treatment of heart failure in chronic kidney disease
    Marx, Nikolaus
    INTERNIST, 2020, 61 (04): : 357 - 361
  • [38] The Prognostic Role of RDW in Hospitalized Heart Failure Patients with and Without Chronic Kidney Disease
    Giamouzis, Grigorios
    Kourek, Christos
    Magouliotis, Dimitrios E.
    Briasoulis, Alexandros
    Zakynthinos, George E.
    Sawafta, Assaf
    Iakovis, Nikolaos
    Afxonidis, Georgios
    Spiliopoulos, Kyriakos
    Triposkiadis, Filippos
    Athanasiou, Thanos
    Skoularigis, John
    Xanthopoulos, Andrew
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (23)
  • [39] Hyponatremia, Hypernatremia, and Mortality in Patients With Chronic Kidney Disease With and Without Congestive Heart Failure
    Kovesdy, Csaba P.
    Lott, Evan H.
    Lu, Jun Ling
    Malakauskas, Sandra M.
    Ma, Jennie Z.
    Molnar, Miklos Z.
    Kalantar-Zadeh, Kamyar
    CIRCULATION, 2012, 125 (05) : 677 - 684
  • [40] Incidence of clinical outcomes in heart failure patients with and without advanced chronic kidney disease
    Anjum, Deewa Zahir
    Bonde, Anders N.
    Fosbol, Emil
    Garred, Caroline Hartwell
    Gislason, Gunnar
    Elmegaard, Mariam
    Knigge, Pauline
    Torp-Pedersen, Christian
    Andersson, Charlotte
    Pfeffer, Marc A.
    Jhund, Pardeep S.
    McMurray, John J. V.
    Petrie, Mark C.
    Kober, Lars
    Schou, Morten
    ESC HEART FAILURE, 2024, 11 (05): : 2481 - +
12345